Status:
COMPLETED
Evaluation Of A Novel Methodology In The Assessment Of Urethral Function Using SS-RBX.
Lead Sponsor:
Pfizer
Conditions:
Urinary Incontinence, Stress
Eligibility:
FEMALE
18-65 years
Phase:
PHASE2
Brief Summary
SS-RBX will be used to evaluate pharmacodynamic changes in urethral function using a novel methodology
Eligibility Criteria
Inclusion
- Female
- Stress urinary incontinence
Exclusion
- Bladder outflow obstruction
- Neurological disease
Key Trial Info
Start Date :
December 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2006
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT00141128
Start Date
December 1 2005
End Date
June 1 2006
Last Update
June 1 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Glostrup Municipality, Denmark, 2600